Sitagliptin Phosphate Tablets bulk supplier for pharma manufacturers

Sitagliptin Phosphate Tablets 25 mg, 50 mg, 100 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 25 mg, 50 mg, 100 mg

Reference Brands: Januvia(US & EU)

Category: Diabetes

Sitagliptin is a DPP-4 inhibitor that enhances incretin levels, increasing insulin release and decreasing glucagon secretion in a glucose-dependent manner. This improves glycemic control without causing hypoglycemia. It’s weight-neutral, well-tolerated, and effective as monotherapy or in combination therapy for Type 2 diabetes, supporting long-term blood sugar regulation.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Sitagliptin Phosphate Tablets? List it or send an offer →

Product Description:

Sitagliptin, marketed under the brand name Januvia, is a DPP-4 inhibitor approved for managing type 2 diabetes mellitus. In the USA, the FDA approved Sitagliptin in 2006, and it remains under brand protection with limited generic availability. In the EU, it received EMA approval in 2007 and is available in multiple strengths (25 mg, 50 mg, 100 mg). Sitagliptin is used as monotherapy or in combination with other antidiabetic agents. Pharmacovigilance data confirms a favorable safety profile. With patent expirations approaching in some regions, generic versions are beginning to enter select EU markets. Widely sourced via platforms like Pharmatradz.com.

Sitagliptin Phosphate Tablets — third party manufacturing & bulk supply

Sitagliptin Phosphate Tablets 25 mg, 50 mg, 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Sitagliptin Phosphate Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Sitagliptin Phosphate Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Sitagliptin Phosphate Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Sitagliptin Phosphate tablets are used to control blood sugar levels in patients with type 2 diabetes mellitus. They help improve glycemic control by increasing insulin release and decreasing glucose production, especially when used along with diet and exercise.

These tablets are made from sitagliptin phosphate monohydrate, a DPP-4 (dipeptidyl peptidase-4) inhibitor that works by increasing incretin hormones, which help regulate blood sugar by enhancing insulin secretion and reducing glucagon levels.

Common trade names include Januvia (USA, EU, UK), Xelevia (EU), Tesavel (EU), Sitagliptin (generic brands), and various regional brands available in India and LATAM markets.

The original product is developed and marketed by Merck & Co., Inc. (MSD). It is also made by other manufacturers, including in India. We match each enquiry with licensed makers whose documents fit your market.

The complete generic name is sitagliptin phosphate monohydrate.

Brand names include Januvia, Xelevia, Tesavel, and various country-specific generic brands.

Sitagliptin Phosphate tablets are manufactured globally in countries such as the USA, UK, EU nations, India, and LATAM regions by both innovator and generic pharmaceutical companies.